Clinical Scorecard: Invariant T cells associated with mucosal tissues facilitate the advancement of pancreatic ductal adenocarcinoma through the TL1A–CSF-1 pathway
At a Glance
Category
Detail
Condition
Pancreatic ductal adenocarcinoma (PDAC)
Key Mechanisms
MAIT cells promote M2-polarized tumor-associated macrophages via the TL1A–CSF-1 pathway, leading to immunosuppression.
Target Population
Patients with pancreatic ductal adenocarcinoma
Care Setting
Oncology
Key Highlights
Higher MAIT cell infiltration correlates with poor prognosis in PDAC.
MAIT cells in PDAC exhibit an immunosuppressive phenotype.
Deficiency of MAIT cells reduces tumor growth in mouse models.
Guideline-Based Recommendations
Diagnosis
Assess MAIT cell infiltration in tumor tissues for prognostic evaluation.
Management
Consider targeting the TL1A–CSF-1 pathway for therapeutic interventions.
Monitoring & Follow-up
Monitor CA19-9 levels and lymph node metastasis in relation to MAIT cell levels.
Risks
High MAIT cell levels are associated with increased risk of poor outcomes.
Patient & Prescribing Data
Patients diagnosed with pancreatic ductal adenocarcinoma.
MAIT cell levels may inform treatment strategies and prognostic assessments.
Clinical Best Practices
Utilize flow cytometry for evaluating MAIT cell infiltration in tumor tissues.
Implement immunofluorescence staining for assessing MAIT cell presence in tissue microarrays.
